| Metric | Q1 FY27 | Q4 FY26 | Q1 FY26 |
|---|---|---|---|
| Revenue from operations | 177.3 | 187.3 | 154.1 |
| Other income | 24.3 | -4.2 | 15.3 |
| Total income | 201.5 | 183.1 | 169.3 |
| Profit before exceptional items & tax | 47.6 | 16.7 | 35.4 |
| Profit before tax | 47.6 | 16.7 | 35.4 |
| Net profit | 36.2 | 11.6 | 27.7 |
| Operating margin | 23.6% | 9.1% | 20.9% |
A dash means the filing did not report that period; n/m means not meaningful (margin on near-zero revenue). Growth is not shown when either period was a loss. Operating profit excludes other income.
| Net profit, year on year | +30.70% |
|---|---|
| Net profit, quarter on quarter | +212.10% |
| Revenue, year on year | +15.10% |
| Operating profit, year on year | +15.90% |
| Operating profit, quarter on quarter | +11.50% |
BSE results filing, NSE: LINCOLN. Figures extracted from the filing.
Lincoln Pharmaceuticals Ltd: key numbers
- Share price
- ₹591.00
- Market cap
- ₹1,184 Cr
- Revenue (annual)
- ₹671.0 Cr
- Net profit (annual)
- ₹87.89 Cr
- P/E (TTM)
- 12.3×Sector 50.4×
- Promoter holding
- 49.78%+0.00% QoQ
- FII holding
- 4.60%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Lincoln Pharmaceuticals Ltd
All →Lincoln Pharmaceuticals Management Change
Lincoln Pharmaceuticals announced the resignation of Mr. Manoj Rai, Sr. General Manager (Head QA), a Senior Management Personnel. He departs effective 24 September 2026 for personal reasons.
Lincoln Pharmaceuticals Other Announcement
Lincoln Pharmaceuticals has dispatched physical letters to shareholders with unregistered email IDs to provide access to the Annual Report for FY 2025-26 and facilitate KYC updates.
Lincoln Pharmaceuticals Annual Report
Lincoln Pharmaceuticals submitted its Annual Report for FY 2025-26 and notice for the 32nd Annual General Meeting scheduled for September 30, 2026.
Lincoln Pharmaceuticals Q4 FY26 Results: Net Profit ₹11.6 Cr, Up 0.0% YoY
Lincoln Pharmaceuticals Ltd reported revenue from operations of ₹187.3 Cr (+11.4% YoY) and net profit of ₹11.6 Cr (+0.0% YoY) for Q4 FY26.
- Key figure
- Net profit ₹11.6 Cr · +0.0% YoY